Arkolith/Insider Trading/GRTX/Form 4

Chang Nancy T

Director, 10% OwnerGalera Therapeutics, Inc. (GRTX) · full profile →Form 4 · filed Jan 2, 2025
Net Buying
Open-Market Buys
$535K
Open-Market Sells
$0
Net Open-Market Flow
$535K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 30, 2024Buy(P)7.6M$0.07$535K7.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 30, 2024Grant(A)2K—$02K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML